Author | Ben Leach


Higher Dose of Fulvestrant Associated With Improved Survival in Advanced Breast Cancer

December 05, 2012

Postmenopausal women with advanced estrogen receptor–positive breast cancer lived longer when they received a 500-mg dose of fulvestrant as compared with a 250-mg dose.

Sentinel Lymph Node Surgery After Chemotherapy Shows Accuracy in Nodal Staging in Breast Cancer

December 05, 2012

Sentinel lymph node surgery may provide a less-invasive alternative to axillary lymph node dissection for nodal staging in node-positive breast cancer.

FDA Approves Cabozantinib for Medullary Thyroid Cancer

November 29, 2012

The FDA has approved cabozantinib, a multi-targeted tyrosine kinase inhibitor, for the treatment of metastatic medullary thyroid cancer.

Use of Tolvaptan in Hyponatremic Patients Reduces Hospital Costs, Study Finds

April 02, 2012

Tolvaptan, a vasopression V2 receptor antagonist used to increase low levels of sodium in the blood, could be a cost effective way of managing patients who have hyponatremia.